Regulation of activity of the transcription factor GATA-1 by acetylation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DNA. A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p, PCAF, TAF(II)250 and p300/CBP. These acetyltransferases also modify certain transcription factors (TFIIEbeta, TFIIF, EKLF and p53). GATA-1 is an important transcription factor in the haematopoietic lineage and is essential for terminal differentiation of erythrocytes and megakaryocytes. It is associated in vivo with the acetyltransferase p300/CBP. Here we report that GATA-1 is acetylated in vitro by p300. This significantly increases the amount of GATA-1 bound to DNA and alters the mobility of GATA-1-DNA complexes, suggestive of a conformational change in GATA-1. GATA-1 is also acetylated in vivo and acetylation directly stimulates GATA-1-dependent transcription. Mutagenesis of important acetylated residues shows that there is a relationship between the acetylation and in vivo function of GATA-1. We propose that acetylation of transcription factors can alter interactions between these factors and DNA and among different transcription factors, and is an integral part of transcription and differentiation processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBP acetylates GATA-1 at two highly conserved lysine-rich motifs near each of the two zinc fingers (10, 27).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [10]
In the citing paper
“The basic tail of the GATA-1 CF has been shown to undergo a number of post-translational modifications.”
From Molecular Analysis of the Interaction between the Hematopoietic Master Transcription Factors GATA-1 and PU.1 (2006) · cites this paper as [34]
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Self-citationHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“gif" NDATA ITEM> ]> Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DN”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 1×
“These acetyltransferases also modify certain transcription factors (TFIIEβ, TFIIF, EKLF and p53”
BackgroundThe CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S. Y., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,640 · cited 1×
“A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p”
BackgroundA p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
Self-citationPevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V., Orkin, S. H., & Costantini, F. (1991) · Nature · doi:10.1038/349257a0 · Cited by 1,308 · cited 1×
“and is essential for terminal differentiation of erythrocytes and megakaryocyte”
BackgroundA direct link between core histone acetylation and transcriptionally active chromatin.
Hebbes, T. R., Thorne, A. W., & Crane-Robinson, C. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02956.x · Cited by 923
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884 · cited 1×
“GATA-1 is an important transcription factor in the haematopoietic lineag”
BackgroundThe TAFII250 Subunit of TFIID Has Histone Acetyltransferase Activity
Mizzen, C. A., Yang, X.-J., Kokubo, T., Brownell, J. E., Bannister, A. J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S. L., Kouzarides, T., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81821-8 · Cited by 727
Self-citation
Cited by
Items 201–300 of 708
Histone deacetylases as therapeutic targets in hematologic malignancies
Melnick, A., & Licht, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00010 · Cited by 117
Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65
Buerki, C., Rothgiesser, K. M., Valovka, T., Owen, H. R., Rehrauer, H., Fey, M., Lane, W. S., & Hottiger, M. O. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn003 · Cited by 116
“A growing number of transcription factors are acetylated and regulated by p300/CBP including p53 (17), GATA-1 (18), E2F-1 (19,20) and YY1 (21).”
BackgroundHistone deacetylase 3 associates with and represses the transcription factor GATA-2
Ozawa, Y., Towatari, M., Tsuzuki, S., Hayakawa, F., Maeda, T., Miyata, Y., Tanimoto, M., & Saito, H. (2001) · Blood · doi:10.1182/blood.v98.7.2116 · Cited by 113
“Consistent with the interaction in vitro, HDAC3 (1-132) expressed in COS cells could not bind to GST–GATA-2, whereas HDAC3 (1-180) successfully bound to GST–GATA-2 as effectively as full-length HDAC3 (Figure 2D).”
BackgroundConditional MLL‐CBP targets GMP and models therapy‐related myeloproliferative disease
Wang, J., Iwasaki, H., Krivtsov, A. V., Febbo, P. G., Thorner, A. R., Ernst, P., Anastasiadou, E., Kutok, J. L., Kogan, S. C., Zinkel, S. S., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600521 · Cited by 122
“It also depends on the intrinsic ability of CBP to acetylate both histones and transcription factors themselves (Bannister and Kouzarides, 1996; Gu and Roeder, 1997; Boyes et al, 1998).”
BackgroundGuidez, F., Howell, L., Isalan, M., Cebrat, M., Alani, R. M., Ivins, S., Hormaeche, I., McConnell, M. J., Pierce, S., Cole, P. A., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5552-5566.2005 · Cited by 110
“Key hematopoietic transcription factors such as GATA1 (9) and ELKF (83) were also shown to be acetylated in their DNA binding domains leading to enhanced DNA binding and transcriptional activation.”
BackgroundTranscriptional control of erythropoiesis: emerging mechanisms and principles
Kim, S.-I., & Bresnick, E. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210761 · Cited by 140
“GATA-1 is subject to multi-site phosphorylation (Crossley and Orkin, 1994; Zhao et al., 2006) and acetylation (Boyes et al., 1998; Hung et al., 1999), and such modifications could obviously contribute to key steps in GATA-1 function.”
BackgroundRegulation of GATA4 Transcriptional Activity in Cardiovascular Development and Disease
Zhou, P., He, A., & Pu, W. T. (2012) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-387786-4.00005-1 · Cited by 119
“Perhaps consistent with this sequence divergence, GATA1 is often functionally dissimilar from GATA2/3, and changes in chromatin occupancy between GATA1 and GATA2 are important for normal progression of hematopoiesis (Bresnick et al., 2010).”
BackgroundReeves, M. B., & Sinclair, J. H. (2009) · Journal of General Virology · doi:10.1099/vir.0.015602-0 · Cited by 110
Suhara, W., Yoneyama, M., Kitabayashi, I., & Fujita, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200192200 · Cited by 121
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition
Tong, X., Yin, L., & Giardina, C. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.066 · Cited by 119
Functional analysis of a RPD3 histone deacetylase homologue in Arabidopsis thaliana
Wu, K., Malik, K., Tian, L., Brown, D. C., & Miki, B. L. A. (2000) · Plant Molecular Biology · doi:10.1023/a:1006498413543 · Cited by 128
“The finding that non-histone proteins are also regulated by acetylation in mammalian cells (Gu and Roeder, 1997; Imhof et al., 1997; Sakaguchi et al., 1998; Zhang and Bieker, 1998; Boyes et al., 1999) also raises the possibility that histone deacetylases may also target non-histone proteins for deacetylation.”
BackgroundMahmud, D. L., G-Amlak, M., Deb, D. K., Platanias, L. C., Shahab Uddin, M. S., & Wickrema, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205230 · Cited by 123
“The erythroid speci®c transcription factor GATA1 and the tumor suppressor p53 are acetylated by p300 and such acetylation upregulates the transcription by these factors (Gu and Roeder 1997; Boyes et al., 1998).”
BackgroundOikawa, T., Yamada, T., Kihara-Negishi, F., Yamamoto, H., Kondoh, N., Hitomi, Y., & Hashimoto, Y. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400534 · Cited by 109
“Beside histones, p300/CBP can directly modify the C-terminal domain of the p53 tumor suppressor protein and the DNA binding domain of the erythroid transcription factor GATA-1 by acetylation to stimulate their DNA binding activities.(102,103) It has been reported that CBP is required for differentiation of muscle and…”
BackgroundTell, G. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.5.1099 · Cited by 109
Santangelo, S., Cousins, D. J., Winkelmann, N. E. E., & Staynov, D. Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1893 · Cited by 108
Angus-Hill, M. L., Dutnall, R. N., Tafrov, S. T., Sternglanz, R., & Ramakrishnan, V. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3338 · Cited by 118
“…notably p300/CBP, are also capable of modifying non-histone substrates, which makes # 1999 Academic Press it possible that these enzymes in¯uence transcriptional activity via mechanisms that do not involve chromatin (Boyes et al., 1998; Gu & Roeder, 1997; Imhof et al., 1997; Waltzer & Bienz, 1998).”
BackgroundRaval, A., Howcroft, T. K., Weissman, J. D., Kirshner, S., Zhu, X.-S., Yokoyama, K. K., Ting, J. P. ‐., & Singer, D. S. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00159-9 · Cited by 123
“The other set of substrates consists of various transcription factors, Aparna Raval,* T. Kevin Howcroft,* Jocelyn D. Weissman,* Susan Kirshner,* Xin-Sheng Zhu,† Kazunari Yokoyama,‡ Jenny Ting,† and Dinah S. Singer*§ *Experimental Immunology Branch such as p53, HMG-1, and GATA-1 (Gu and Roeder, 1997;National Cancer Ins…”
BackgroundAcetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA‐1
Hernández‐Hernández, Á., Ray, P., Litos, G., Cirò, M., Ottolenghi, S., Beug, H., & Boyes, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601228 · Cited by 119
“Cells were harvested 48–72h after transfection; GATA-1 was immunoprecipitated as described (Boyes et al, 1998).”
BackgroundMethodInfluentialSelf-citationCheng, F., Lienlaf, M., Wang, H.-W., Perez-Villarroel, P., Lee, C., Woan, K., Rock-Klotz, J., Sahakian, E., Woods, D., Pinilla-Ibarz, J., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302778 · Cited by 106
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Wawruszak, A., Kalafut, J., Okon, E., Czapinski, J., Halasa, M., Przybyszewska, A., Miziak, P., Okla, K., Rivero-Muller, A., & Stepulak, A. (2019) · Cancers · doi:10.3390/cancers11020148 · Cited by 102
“GATA-1 is an important transcription factor in hematopoiesis and terminal differentiation of erythrocytes and megakaryocytes [72].”
BackgroundHistone Deacetylases Augment Cytokine Induction of the iNOS Gene
Yu, Z., Zhang, W., & Kone, B. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000024253.59665.f1 · Cited by 111
“Acetylation has been shown to regulate many transcription factors other than NF- B, such as p53 (34), E1A (35), GATA-1 (36), and MyoD (37).”
BackgroundSisk, T. J., Gourley, T. S., Roys, S., & Chang, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2511 · Cited by 114
“Intrinsic histone acetyltransferase activity has been found in CBP/p300, which is considered to play a crucial role in transcription from tightly packed chromatin (20).”
BackgroundMechanisms of P/CAF auto-acetylation
Santos-Rosa, H. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg655 · Cited by 105
Factor-specific modulation of CREB-binding protein acetyltransferase activity
Perissi, V., Dasen, J. S., Kurokawa, R., Wang, Z., Korzus, E., Rose, D. W., Glass, C. K., & Rosenfeld, M. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3652 · Cited by 104
Functional regulation of GATA-2 by acetylation
Hayakawa, F. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603289 · Cited by 99
“Acetylation of GATA-1 enhances transactivation capacity and is required for its biological function, the induction of erythroid differentiation, although its effect on DNA-binding activity is still unconfirmed [21, 22].”
BackgroundInfluentialIncreased Affinity of c-Myb for CREB-binding Protein (CBP) after CBP-induced Acetylation
Sano, Y., & Ishii, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006896200 · Cited by 116
Interaction between Acetylated MyoD and the Bromodomain of CBP and/or p300
Polesskaya, A., Naguibneva, I., Duquet, A., Bengal, E., Robin, P., & Harel-Bellan, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5312-5320.2001 · Cited by 101
“In vitro, HATs are also able to acetylate nonhistone proteins, in particular, general transcription factors such as TFIIE and TFIIF (13) and numerous sequence-specific transcription factors (5, 11, 16, 20, 31), including myogenic factor MyoD (28).”
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Chüeh, A. C., Tse, J. W. T., Tögel, L., & Mariadason, J. M. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5863 · Cited by 112
Grimwade, D. J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01501.x · Cited by 106
“Recent studies have also suggested that acetylation can directly in¯uence the functional activity of transcription factors implicated in haemopoiesis, such as EKLF and GATA-1 (Zhang & Bieker, 1998; Boyes et al, 1998).”
BackgroundEpigenetic Dysregulation in Cancer
Muntean, A. G., & Hess, J. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081142 · Cited by 116
Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis
Sadlon, T., Dell’Oso, T., Surinya, K. H., & May, B. K. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00073-4 · Cited by 111
Takaya, T., Kawamura, T., Morimoto, T., Ono, K., Kita, T., Shimatsu, A., & Hasegawa, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707391200 · Cited by 97
Asano, Y., Czuwara, J., & Trojanowska, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703907200 · Cited by 104
Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1
Chen, K., Hsieh, I.-C., Hsi, E., Wang, Y., Dai, C., Chou, W., & Juo, S. H. (2011) · Journal of Cell Science · doi:10.1242/jcs.092767 · Cited by 103
“By contrast, GATA-1 and C/ EBPb are both transcriptional activators (Boyes et al., 1998; Ruminy et al., 2001).”
BackgroundIwabata, H., Yoshida, M., & Komatsu, Y. (2005) · PROTEOMICS · doi:10.1002/pmic.200500042 · Cited by 96
Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation
Watamoto, K., Towatari, M., Ozawa, Y., Miyata, Y., Okamoto, M., Abe, A., Naoe, T., & Saito, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206902 · Cited by 104
“It has been reported that GATA1 is acetylated by CBP/p300 HATs, and its acetylation is essential for erythroid differentiation (Boyes et al., 1998).”
BackgroundHata, S., Hirayama, J., Kajiho, H., Nakagawa, K., Hata, Y., Katada, T., Furutani-Seiki, M., & Nishina, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334714 · Cited by 95
Developmental control via GATA factor interplay at chromatin domains
Bresnick, E. H., Martowicz, M. L., Pal, S., & Johnson, K. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20393 · Cited by 96
Lan, Q., & Han, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100011 · Cited by 103
“After blocking with 5% donkey serum in PBS, specimens were further incubated overnight with 4 g/ml of the primary antibody (anti-MMP9, sc-6841, Santa Cruz Biotechnology), anti-MMP13 (AB8120, Millipore), and antidesmin (sc-7559, Santa Cruz Biotechnology and ab8592, Abcam).”
BackgroundInfluentialCytokine memory of T helper lymphocytes
Löhning, M., Richter, A., & Radbruch, A. (2002) · Advances in immunology · doi:10.1016/s0065-2776(02)80014-1 · Cited by 110
CCAAT/Enhancer-binding Protein (C/EBP) β Is Acetylated at Multiple Lysines
Ceseña, T. I., Cardinaux, J., Kwok, R. P. S., & Schwartz, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511451200 · Cited by 110
Bhattacharyya, S., Ghosh, A. K., Pannu, J., Mori, Y., Takagawa, S., Chen, G., Trojanowska, M., Gilliam, A. C., & Varga, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20996 · Cited by 89
Beuck, S., Schänzer, W., & Thevis, M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.390 · Cited by 101
Acetylation of proteins as novel target for antitumor therapy: Review article
Gennaro, E. D., Bruzzese, F., Caraglia, M., Abruzzese, A., & Budillon, A. (2004) · Amino Acids · doi:10.1007/s00726-004-0087-3 · Cited by 103
“Acetylation of other proteins such as transcription factors, rather than histones, has been described (Table 2) including p53 (Gu and Roeder, 1997), GATA-1 (Boyes et al., 1998) and NF-Y (Jin and Scotto, 1998).”
BackgroundGranja, A. G., Nogal, M. L., Hurtado, C., del Aguila, C., Carrascosa, Á. L., Salas, M. L., Fresno, M., & Revilla, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.451 · Cited by 93
Regulation of Inducible Nitric Oxide Synthase Expression by p300 and p50 Acetylation
Deng, W.-G., & Wu, K. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6581 · Cited by 91
“The p50 NF- B isoform joins several transcriptional activators including p53, GATA-1 whose DNA binding activities have been shown to be enhanced by p300-catalyzed acetylation (12, 24).”
BackgroundAcetylation of GATA-1 is required for chromatin occupancy
Lamonica, J. M., Vakoc, C. R., & Blobel, G. A. (2006) · Blood · doi:10.1182/blood-2006-07-032847 · Cited by 84
Post-translational modifications of the progesterone receptors
Abdel-Hafiz, H. A., & Horwitz, K. B. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.12.008 · Cited by 83
Trievel, R. C., Li, F.-Y., & Marmorstein, R. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4855 · Cited by 102
Adam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Schoonbroodt, S., Goffin, V., Nguyên, T. L.-A., Gloire, G., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6200-6209.2003 · Cited by 103
“For some of these transcription factors—such as p53 (21) and GATA-1 (7)—acetylation has been shown to lead to increased DNA binding and transactivation capacities.”
BackgroundDebes, J. D., Comuzzi, B., Schmidt, L. J., Dehm, S. M., Culig, Z., & Tindall, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2837 · Cited by 92
Kinetic and Mass Spectrometric Analysis of p300 Histone Acetyltransferase Domain Autoacetylation
Karanam, B., Jiang, L., Wang, L., Kelleher, N. L., & Cole, P. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608813200 · Cited by 90
The PCAF acetylase complex as a potential tumor suppressor
Schiltz, R. L., & Nakatani, Y. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00037-2 · Cited by 103
Self-citationJacob, A. L., Lund, J., Martinez, P., & Hedin, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104427200 · Cited by 90
Histone Deacetylases as Transcriptional Activators? Role Reversal in Inducible Gene Regulation
Nusinzon, I., & Horvath, C. M. (2005) · Science's STKE · doi:10.1126/stke.2962005re11 · Cited by 90
Acetylation of the human DNA glycosylase NEIL2 and inhibition of its activity
Bhakat, K. K. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh632 · Cited by 92
Huang, S., Qiu, Y., Shi, Y., Xu, Z., & Brandt, S. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6792 · Cited by 103
Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics
Kaypee, S., Sudarshan, D., Shanmugam, M. K., Mukherjee, D., Sethi, G., & Kundu, T. K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.011 · Cited by 97
Huang, S., & Brandt, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2248-2259.2000 · Cited by 89
“As the binding preferences of TAL1-E2A heterodimers (50) differ from those of complexes containing TAL1, GATA-1, Ldb-1, and LMO1 or LMO2 (103), specific sequence elements could by dictating the composition of the DNA-binding complexes influence whether TAL1 stimulates or represses transcription.”
Papoutsopoulou, S., & Janknecht, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7300-7310.2000 · Cited by 88
“Moreover, CBP/p300 directly acetylates transcription factors such as GATA-1 (6) and p53 (21).”
BackgroundKerenyi, M. A., & Orkin, S. H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20102260 · Cited by 88
“For example, GATA-1 is acetylated (Boyes et al., 1998), and this modification appears to be important JEM VOL. 207, November 22, 2010 2539 by cooccupancy of ETO2/Mtgr1 at a subset of SCL/TAL1 target genes (Soler et al., 2010), as well as de-repression of some SCL/TAL1 target genes upon depletion of…”
BackgroundSuzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., & Oikawa, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207182 · Cited by 87
“…post-translational modification of proteins plays important roles for regulation of function of the proteins in the cases of histone proteins and transcription factors including p53 (Sakaguchi et al., 1998), GATA-1 (Boyes et al., 1998), NF-kB (Furia et al., 2002) and MyoD (Sartorelli et al., 1999).”
BackgroundChen, Z., Clark, S., Birkeland, M., Sung, C.-M., Lago, A., Liu, R., Kirkpatrick, R., Johanson, K., Winkler, J. D., & Hu, E. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00322-1 · Cited by 87
“acetyl groups onto and from e-NH2 of lysine residues of proteins including histone, transcription factors and co-factors [1–6].”
BackgroundBabić, I., Jakymiw, A., & Fujita, D. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207484 · Cited by 99
“For example, CBP can acetylate the transcription factors p53 (Gu and Roeder, 1997), E2F1 (Martinez-Balbas et al., 2000), GATA-1 (Boyes et al., 1998), and EKLF (Zhang and Bieker, 1998).”
BackgroundAMF-1/Gps2 Binds p300 and Enhances Its Interaction with Papillomavirus E2 Proteins
Peng, Y.-C., Breiding, D. E., Sverdrup, F. M., Richard, J. G., & Androphy, E. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.5872-5879.2000 · Cited by 96
“GST-p300 fusion expression vectors were kindly provided by Steven R. Grossman and David M. Livingston.”
BackgroundMethodInfluentialRegulation of E2A Activities by Histone Acetyltransferases in B Lymphocyte Development
Bradney, C. P., Hjelmeland, M. D., Komatsu, Y., Yoshida, M., Yao, T., & Zhuang, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211464200 · Cited by 96
Histone modification enzymes: novel targets for cancer drugs
Kristeleit, R. S., Stimson, L., Workman, P., & Aherne, W. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.9.1.135 · Cited by 95
“In addition, some HATs, for example p300, CBP and PCAF, are able to acetylate proteins other than histones, such as the transcription factors p53 [35,36], E2F [38] and GATA-1 [39], generally enhancing their DNA-binding affinity [27,31].”
BackgroundIshiko, E., Matsumura, I., Ezoe, S., Gale, K. B., Ishiko, J., Satoh, Y., Tanaka, H., Shibayama, H., Mizuki, M., Era, T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406788200 · Cited by 97
p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein
Huang, S., Qiu, Y., Stein, R. W., & Brandt, S. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202889 · Cited by 96
“Although not yet investigated for the LIM domain proteins, GATA-1 was found recently to interact directly with CBP (Blobel et al., 1998) and p300 (Boyes et al., 1998).”
BackgroundMethodCBP/p300 acetyltransferase activity in hematologic malignancies
Dutta, R., Tiu, B. C., & Sakamoto, K. M. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.06.013 · Cited by 90
Histone acetyl transferases: a role in DNA repair and DNA replication
Hasan, S., & Hottiger, M. O. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0341-7 · Cited by 92
“They include transcriptional activators such as E2F [67], p53 [68], EKLF [69], GATA1 [70],”
Chen, C.-J., Deng, Z., Kim, A. Y., Blobel, G. A., & Lieberman, P. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.476-487.2001 · Cited by 84
“The LCR consists of multiple binding sites for NF-E2, GATA-1, and EKLF.”
BackgroundInfluentialStimulation of NF-E2 DNA Binding by CREB-binding Protein (CBP)-mediated Acetylation
Hung, H.-L., Kim, A. Y., Hong, W., Rakowski, C., & Blobel, G. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007846200 · Cited by 85
SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis
Yu, L., Ji, W., Zhang, H., Renda, M. J., He, Y., Lin, S., Cheng, E.-C., Chen, H., Krause, D. S., & Min, W. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092215 · Cited by 81
“…function of GATA1 can be regulated by an array of posttranslational modifications, including phosphorylation and acetylation as well as SUMOylation (Boyes et al., 1998; Cantor and Orkin, 2002; Collavin et al., 2004; Yu et al., 2005; Hernandez-Hernandez et al., 2006; Lamonica et al., 2006; Zhao et…”
BackgroundInfluentialThe Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity
Fu, M., Rao, M., Wu, K., Wang, C., Zhang, X., Hessien, M., Yeung, Y.-G., Gioeli, D., Weber, M. J., & Pestell, R. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313466200 · Cited by 82
Kuhl, C., Atzberger, A., Iborra, F. J., Nieswandt, B., Porcher, C., & Vyas, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8592-8606.2005 · Cited by 92
“CBP) (3, 6, 9, 33, 37, 44, 71) transcriptional regulators have”
Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Kim, E., Bisson, W. H., Löhr, C. V., Williams, D. E., Ho, E., Dashwood, R. H., & Rajendran, P. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150825125857 · Cited by 88
The discovery and development of romidepsin for the treatment of T-cell lymphoma
Smolewski, P., & Robak, T. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1341487 · Cited by 89
“response modifiers are preferred over chemotherapy [13,24].”
BackgroundStructure and Specificity of GATA Proteins in Th2 Development
Ranganath, S., & Murphy, K. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2716-2725.2001 · Cited by 84
“lation (2, 3), which can modify the ability of GATA-1 to inter-”
BackgroundLife and death of transcriptional co-activator p300
Chen, J., & Li, Q. (2011) · Epigenetics · doi:10.4161/epi.6.8.16065 · Cited by 92
“It serves not only as a histone acetyltransferase (HAT), but also as a factor acetyltransferase (FAT) for many transcription regulators through a hit-and-run mechanism.(4-11) Besides having an acetyltransferase domain, p300 also contains several conserved functional domains through which it interacts with other cellul…”
BackgroundSuzuki, Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.02.007 · Cited by 89
Chen, W.-Y., Juan, L.-J., & Chung, B.-C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10442-10453.2005 · Cited by 79
“(44), GATA-1 (4), and androgen receptor (AR) (14).”
BackgroundInfluentialGeromanos, S., Freckleton, G., & Tempst, P. (2000) · Analytical Chemistry · doi:10.1021/ac991071n · Cited by 78
Li, Q., Imhof, A., Collingwood, T. N., Urnov, F. D., & Wolffe, A. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5634 · Cited by 78
“An explanation for this variation may lie either in specific aspects of nucleoprotein architecture to which histone acetylation might contribute (van Holde, 1993), or in the recognition that acetyltransferases modify many transcriptional regulators aside from the histones (Gu and Roeder, 1997; Imhof et al., 1997; Boye…”
BackgroundCheong, J., Chong, S. Y., Kim, J. Y., Eom, J.-I., Jeung, H. K., Maeng, H. M., Lee, S., & Min, Y. H. (2003) · PubMed · Cited by 86
Chromatin-mediated regulation of cytomegalovirus gene expression
Reeves, M. B. (2010) · Virus Research · doi:10.1016/j.virusres.2010.09.019 · Cited by 83
“Furthermore, both IE72 and IE86 physically interact with HATs, HDACs and HMTs in a complex pattern of cellular and viral gene regulation.”
BackgroundImpact of protein acetylation in inflammatory lung diseases
Ito, K., Charron, C. E., & Adcock, I. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.009 · Cited by 81
Sleiman, S. F., Basso, M., Mahishi, L., Kozikowski, A. P., Donohoe, M. E., Langley, B., & Ratan, R. R. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902810345 · Cited by 74
“In addition to their role in regulating chromatin structure and gene expression, HDACs deacetylate non-histone proteins such as p53 [1,2], Sp1 [3], E2F [4,5], cAMP response-element-binding protein (CREB) [6], GATA1 [7,8] and tubulin [9].”
Cooperative Activation by GATA-4 and YY1 of the Cardiac B-type Natriuretic Peptide Promoter
Bhalla, S. S., Robitaille, L., & Nemer, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100208200 · Cited by 87
Functional Interaction between Coactivators CBP/p300, PCAF, and Transcription Factor FKLF2
Song, C.-Z., Keller, K. L., Murata, K., Asano, H., & Stamatoyannopoulos, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108826200 · Cited by 87
Acetylation of the response regulator, CheY, is involved in bacterial chemotaxis
Barak, R., & Eisenbach, M. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02425.x · Cited by 82
Skov, S., Rieneck, K., Bovin, L. F., Skak, K., Tomra, S., Michelsen, B. K., & Ødum, N. (2003) · Blood · doi:10.1182/blood-2002-07-2073 · Cited by 81
Imidazole Ring-Opened DNA Purines and Their Biological Significance
Tudek, B. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.012 · Cited by 87
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Hong, W., Kim, A. Y., Ky, S., Rakowski, C., Seo, S.-B., Chakravarti, D., Atchison, M., & Blobel, G. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3729-3743.2002 · Cited by 74
“CBP acetylates GATA-1 at two highly conserved lysine-rich motifs near each of the two zinc fingers (10, 27).”
BackgroundThe Tumor Suppressor p53 Abrogates Smad-dependent Collagen Gene Induction in Mesenchymal Cells
Ghosh, A. K., Bhattacharyya, S., & Varga, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403477200 · Cited by 74
Histone deacetylases in viral infections
Herbein, G., & Wendling, D. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0003-5 · Cited by 82
“The covalent modifications of several transcriptional factors, including E2F, sp3, p53, GATA1, and TFIIF, have been reported (Ammanamanchi et al. 2003; Boyes et al. 1998; Braun et al. 2001; Gu and Roeder 1997; Imhof et al. 1997; Marzio et al. 2000).”
BackgroundVanOosten, R. L., Moore, J. M., Ludwig, A. T., & Griffith, T. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.008 · Cited by 80
Umetani, M., Mataki, C., Minegishi, N., Yamamoto, M. P., Hamakubo, T., & Kodama, T. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.917 · Cited by 79
Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages
Han, S., & Lee, J. K. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1418-4 · Cited by 73
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
Shirakawa, K., Wang, L., Man, N., Maksimoska, J., Sorum, A. W., Lim, H. W., Lee, I. S., Shimazu, T., Newman, J. C., Schröder, S., et al. (2016) · eLife · doi:10.7554/elife.11156 · Cited by 71
“pCi-p300 and pCi-PCAF are described elsewhere (Boyes et al., 1998).”
Metadata
- Authors
- Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V.
- Affiliations
- Institute of Cancer Research (GB)
- Hammersmith Hospital (GB)
- National Institutes of Health (US)
- Corresponding author
- Boyes, Joan
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6711
- Pages
- 594-598
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1626483287
- Cited by
- 694
- References
- 28
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 14 · 2013: 14 · 2012: 15
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- GATA-1, histone acetylation, CBP/p300, transcriptional coactivator, histone acetyltransferase, protein conformational change, erythroid differentiation, acetylation sites
- MeSH terms
- Acetylation, Amino Acid Sequence, Animals, Binding Sites, Chickens, DNA, DNA-Binding Proteins, Lysine, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Mass Spectrometry, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Trans-Activators, Zinc Fingers, 3T3 Cells, E1A-Associated p300 Protein, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.